The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
The interaction of hepatic lipid and glucose metabolism in liver diseases
Open accessAbstract
It is widely known that the liver is a central organ in lipogenesis, gluconeogenesis and cholesterol metabolism. However, over the last decades, a variety of pathological conditions highlighted the importance of metabolic functions within the diseased liver. As observed in Western societies, an increase in the prevalence of obesity and the metabolic syndrome promotes pathophysiological changes that cause non-alcoholic fatty liver disease (NAFLD). NAFLD increases the susceptibility of the liver to acute liver injury and may lead to cirrhosis and hepatocellular cancer. Alterations in insulin response, β-oxidation, lipid storage and transport, autophagy and an imbalance in chemokines and nuclear receptor signaling are held accountable for these changes. Furthermore, recent studies revealed a role for lipid accumulation in inflammation and ER stress in the clinical context of liver regeneration and hepatic carcinogenesis. This review focuses on novel findings related to nuclear receptor signaling - including the vitamin D receptor and the liver receptor homolog 1 - in hepatic lipid and glucose uptake, storage and metabolism in the clinical context of NAFLD, liver regeneration, and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
(1978) · Biochemical Education · doi:10.1016/0307-4412(78)90049-3 · Cited by 5,046
Autophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802
Self-citationPromotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
Qu, X., Yu, J., Bhagat, G., Furuya, N., Hibshoosh, H., Troxel, A., Rosen, J., Eskelinen, E.-L., Mizushima, N., Ohsumi, Y., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20039 · Cited by 2,311
Jung, C. H., Ro, S.-H., Cao, J., Otto, N. M., & Kim, D.-H. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.017 · Cited by 2,090
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764
The Mitochondrial Carnitine Palmitoyltransferase System — From Concept to Molecular Analysis
McGarry, J. D., & Brown, N. F. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00001.x · Cited by 1,616 · cited 3×
“While short- and medium-chain FAs pass the mitochondrial membrane without activation, activated long-chain fatty acids (LCFAs) are shuttled across the membrane via carnitine palmitoyltransferase-1 (CPT1).”
BackgroundInsulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth
Porstmann, T., Santos, C. R., Griffiths, B., Cully, M., Wu, M., Leevers, S., Griffiths, J. R., Chung, Y.-L., & Schulze, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.007 · Cited by 1,413
Defective Hepatic Autophagy in Obesity Promotes ER Stress and Causes Insulin Resistance
Yang, L., Li, P., Fu, S., Calay, E. S., & Hotamisligil, G. S. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.005 · Cited by 1,274 · cited 3×
“Thus, disrupted autophagy might be essential to the pathogenesis of NASH via lipotoxicity-induced ER stress [12].”
BackgroundPostic, C., & Girard, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34275 · Cited by 1,204
Lipid-induced insulin resistance: unravelling the mechanism
Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60408-4 · Cited by 1,189
CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior
Silverstein, R. L., & Febbraio, M. (2009) · Science Signaling · doi:10.1126/scisignal.272re3 · Cited by 1,141
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085
Self-citationNeuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.23719 · Cited by 1,077
Fu, S., Yang, L., Li, P., Hofmann, O., Dicker, L., Hide, W., Lin, X., Watkins, S. M., Ivanov, A. R., & Hotamisligil, G. S. (2011) · Nature · doi:10.1038/nature09968 · Cited by 1,020
Self-citationYamaguchi, K., Yang, L., McCall, S., Huang, J., Yu, X. X., Pandey, S. K., Bhanot, S., Monia, B. P., Li, Y.-X., & Diehl, A. M. (2007) · Hepatology · doi:10.1002/hep.21655 · Cited by 1,015
Abumrad, N. A., el-Maghrabi, M. R., Amri, E. Z., Lopez, E., & Grimaldi, P. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46753-6 · Cited by 1,002
Nguyen, P., Leray, V., Diez, M., Serisier, S., Bloc’h, J. L., Siliart, B., & Dumon, H. (2008) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/j.1439-0396.2007.00752.x · Cited by 968
Enzymes of triacylglycerol synthesis and their regulation
Coleman, R. (2004) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00051-1 · Cited by 965
The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective
Venook, A. P., Papandreou, C., Furuse, J., & Ladrón de Guevara, L. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-s4-05 · Cited by 965
Feldstein, A. E., Werneburg, N. W., Canbay, A., Guicciardi, M. E., Bronk, S. F., Rydzewski, R., Burgart, L. J., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20283 · Cited by 834
Self-citationLi, S., Brown, M. S., & Goldstein, J. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914798107 · Cited by 733 · cited 1×
“Interestingly, rapamycin treatment also downregulates SREBP-1c in primary hepatocytes, which suggests an effect of rapamycin, independent of mTOR, on the activity of forkhead box protein O (FoxO) [40].”
BackgroundPivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Villanueva, A., Chiang, D. Y., Newell, P., Peix, J., Thung, S., Alsinet, C., Tovar, V., Roayaie, S., Minguez, B., Sole, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.08.008 · Cited by 733
Kammoun, H. L., Chabanon, H., Hainault, I., Luquet, S., Magnan, C., Koike, T., Ferré, P., & Foufelle, F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37007 · Cited by 732
Feldstein, A. E., Wieckowska, A., Lopez, R. A., Liu, Y.-C., Zein, N. N., & McCullough, A. J. (2009) · Hepatology · doi:10.1002/hep.23050 · Cited by 712
Davila, J. A., Morgan, R. O., Shaib, Y., McGlynn, K. A., & El-Serag, H. B. (2005) · Gut · doi:10.1136/gut.2004.052167 · Cited by 704
Crespo, J., Cayón, A., Fernández-Gil, P., Hernández-Guerra, M., Mayorga, M., Domínguez-Díez, A., Fernández-Escalante, J. C., & Pons-Romero, F. (2001) · Hepatology · doi:10.1053/jhep.2001.29628 · Cited by 693
Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration
Huang, W., Ma, K., Zhang, J., Qatanani, M., Cuvillier, J., Liu, J., Dong, B., Huang, X., & Moore, D. D. (2006) · Science · doi:10.1126/science.1121435 · Cited by 645
Ricchi, M., Odoardi, M. R., Carulli, L., Anzivino, C., Ballestri, S., Pinetti, A., Fantoni, L. I., Marra, F., Bertolotti, M., Banni, S., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05733.x · Cited by 645
Ratziu, V., Giral, P., Jacqueminet, S., Charlotte, F., Hartemann–Heurtier, A., Serfaty, L., Podevin, P., Lacorte, J., Bernhardt, C., Bruckert, E., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.078 · Cited by 625
Gregor, M. F., & Hotamisligil, G. S. (2007) · Journal of Lipid Research · doi:10.1194/jlr.r700007-jlr200 · Cited by 586
Rutkowski, D. T., Wu, J., Back, S.-H., Callaghan, M. U., Ferris, S. P., Iqbal, J., Clark, R., Miao, H., Hassler, J. R., Fornek, J., et al. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.10.015 · Cited by 580
Identification of a Physiologically Relevant Endogenous Ligand for PPARα in Liver
Chakravarthy, M. V., Lodhi, I. J., Yin, L., Malapaka, R. R. V., Xu, H. E., Turk, J., & Semenkovich, C. F. (2009) · Cell · doi:10.1016/j.cell.2009.05.036 · Cited by 533
Gupta, N. A., Mells, J., Dunham, R. M., Grakoui, A., Handy, J., Saxena, N. K., & Anania, F. A. (2010) · Hepatology · doi:10.1002/hep.23569 · Cited by 532
Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease
Kohjima, M., Enjoji, M., Higuchi, N., Kato, M., Kotoh, K., Yoshimoto, T., Fujino, T., Yada, M., Yada, R., Harada, N., et al. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.20.3.351 · Cited by 529
Merkel, M., Eckel, R. H., & Goldberg, I. J. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200015-jlr200 · Cited by 522
Erbay, E., Babaev, V. R., Mayers, J. R., Makowski, L., Charles, K. N., Snitow, M. E., Fazio, S., Wiest, M. M., Watkins, S. M., Linton, M. F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2067 · Cited by 485
Self-citationRoach, P. (2002) · Current Molecular Medicine · doi:10.2174/1566524024605761 · Cited by 468
Free fatty acids and insulin resistance
Delarue, J., & Magnan, C. (2007) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328042ba90 · Cited by 466
Liver-Specific Inhibition of ChREBP Improves Hepatic Steatosis and Insulin Resistance in ob/ob Mice
Dentin, R., Benhamed, F., Hainault, I., Fauveau, V., Foufelle, F., Dyck, J. R. B., Girard, J., & Postic, C. (2006) · Diabetes · doi:10.2337/db06-0200 · Cited by 433
Jiang, H.-Y., Wek, S. A., McGrath, B. C., Scheuner, D., Kaufman, R. J., Cavener, D. R., & Wek, R. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5651-5663.2003 · Cited by 423
Adiponectin and its receptors in non-alcoholic steatohepatitis
Kaser, S., Moschen, A., Cayon, A., Kaser, A., Crespo, J., Pons-Romero, F., Ebenbichler, C. F., Patsch, J. R., & Tilg, H. (2005) · Gut · doi:10.1136/gut.2003.037010 · Cited by 412
Human fat cell lipolysis: biochemistry, regulation and clinical role.
Arner, P. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.004 · Cited by 401
Glucokinase and molecular aspects of liver glycogen metabolism
Agius, L. (2008) · Biochemical Journal · doi:10.1042/bj20080595 · Cited by 384
Rautou, P.-E., Mansouri, A., Lebrec, D., Durand, F., Valla, D., & Moreau, R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.006 · Cited by 383
PPARα: Energy Combustion, Hypolipidemia, Inflammation and Cancer
Pyper, S. R., Viswakarma, N., Yu, S., & Reddy, J. K. (2010) · Nuclear Receptor Signaling · doi:10.1621/nrs.08002 · Cited by 379
PPARγ2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes
Schadinger, S. E., Bucher, N. L. R., Schreiber, B. M., & Farmer, S. R. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00513.2004 · Cited by 376
Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis
Hegardt, F. G. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3380569 · Cited by 374
Hirsch, H. A., Iliopoulos, D., Joshi, A., Zhang, Y., Jaeger, S. A., Bulyk, M., Tsichlis, P. N., Shirley Liu, X., & Struhl, K. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.022 · Cited by 359
II. Cytochrome P-450 enzymes and oxidative stress
Robertson, G., Leclercq, I., & Farrell, G. C. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.5.g1135 · Cited by 358
Hepatic Autophagy Is Suppressed in the Presence of Insulin Resistance and Hyperinsulinemia
Liu, H.-Y., Han, J., Cao, S. Y., Hong, T., Zhuo, D., Shi, J., Liu, Z., & Cao, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033936 · Cited by 352
Dentin, R., Girard, J., & Postic, C. (2005) · Biochimie · doi:10.1016/j.biochi.2004.11.008 · Cited by 328
Proteolytic and lipolytic responses to starvation
Finn, P. F., & Dice, J. F. (2006) · Nutrition · doi:10.1016/j.nut.2006.04.008 · Cited by 321
Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice
Feldstein, A. E., Canbay, A., Guicciardi, M. E., Higuchi, H., Bronk, S. F., & Gores, G. J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00460-4 · Cited by 320
Self-citationAlcoholic steatosis and steatohepatitis.
Maher, J. J. (2002) · PubMed · Cited by 315
Valera, A., Pujol, A., Pelegrin, M., & Bosch, F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9151 · Cited by 301
The role of the lipogenic pathway in the development of hepatic steatosis
Postic, C., & Girard, J. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)74599-3 · Cited by 288
Regulation of Carbohydrate Metabolism by the Farnesoid X Receptor
Stayrook, K. R., Bramlett, K. S., Savkur, R. S., Ficorilli, J., Cook, T., Christe, M. E., Michael, L. F., & Burris, T. P. (2005) · Endocrinology · doi:10.1210/en.2004-0965 · Cited by 288
Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease
Tamura, S., & Shimomura, I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524930 · Cited by 287
Taniguchi, C. M., Kondo, T., Sajan, M., Luo, J., Bronson, R., Asano, T., Farese, R., Cantley, L. C., & Kahn, C. R. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.005 · Cited by 279
Doege, H., Baillie, R. A., Ortegon, A. M., Tsang, B., Wu, Q., Punreddy, S., Hirsch, D., Watson, N., Gimeno, R. E., & Stahl, A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.006 · Cited by 279
Caveolin-1 Is Essential for Liver Regeneration
Fernández, M. A., Albor, C., Ingelmo-Torres, M., Nixon, S. J., Ferguson, C., Kurzchalia, T., Tebar, F., Enrich, C., Parton, R. G., & Pol, A. (2006) · Science · doi:10.1126/science.1130773 · Cited by 272
Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes
Han, M. S., Park, S. Y., Shinzawa, K., Kim, S., Chung, K. W., Lee, J.-H., Kwon, C. H., Lee, K.-W., Lee, J.-H., Park, C. K., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700184-jlr200 · Cited by 257
Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome
Fessler, M. B., Rudel, L. L., & Brown, J. M. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832fa5c4 · Cited by 249
GLUT2 mutations, translocation, and receptor function in diet sugar managing
Leturque, A., Brot-Laroche, E., & Le Gall, M. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00004.2009 · Cited by 245
Non-alcoholic Steatohepatitis and Cancer
Bugianesi, E. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.006 · Cited by 245
Atf4 Regulates Obesity, Glucose Homeostasis, and Energy Expenditure
Seo, J., Fortuno, E. S., Suh, J. M., Stenesen, D., Tang, W., Parks, E. J., Adams, C. M., Townes, T., & Graff, J. M. (2009) · Diabetes · doi:10.2337/db09-0335 · Cited by 243
III. Peroxisomal β-oxidation, PPARα, and steatohepatitis
Reddy, J. K. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.6.g1333 · Cited by 236
Endo, M., Masaki, T., Seike, M., & Yoshimatsu, H. (2007) · PubMed · Cited by 225
Tanaka, N., Moriya, K., Kiyosawa, K., Koike, K., Gonzalez, F. J., & Aoyama, T. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33594 · Cited by 221
The MAP1-LC3 conjugation system is involved in lipid droplet formation
Shibata, M., Yoshimura, K., Furuya, N., Koike, M., Ueno, T., Komatsu, M., Arai, H., Tanaka, K., Kominami, E., & Uchiyama, Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.039 · Cited by 215
Obesity Affects the Liver – The Link between Adipocytes and Hepatocytes
Wree, A., Kahraman, A., Gerken, G., & Canbay, A. (2011) · Digestion · doi:10.1159/000318741 · Cited by 215
Self-citationIdentification of Caveolin-1 as a Fatty Acid Binding Protein
Trigatti, B. L., Anderson, R. G. W., & Gerber, G. E. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.0123 · Cited by 208
GLUT1 as a therapeutic target in hepatocellular carcinoma
Amann, T., & Hellerbrand, C. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903307509 · Cited by 204
Autophagy in Health and Disease
(2013) · Elsevier eBooks · doi:10.1016/c2010-0-66523-0 · Cited by 194
A role for PPARα in the control of SREBP activity and lipid synthesis in the liver
Knight, B. L., Hebbachi, A., Hauton, D., Brown, A.-M., Wiggins, D., Patel, D. D., & Gibbons, G. F. (2005) · Biochemical Journal · doi:10.1042/bj20041896 · Cited by 188
Temporal pattern of de novo lipogenesis in the postprandial state in healthy men1–3
Timlin, M. T., & Parks, E. J. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.35 · Cited by 172
Bechmann, L. P., Jochum, C., Kocabayoglu, P., Sowa, J.-P., Kassalik, M., Gieseler, R. K., Saner, F., Paul, A., Trautwein, C., Gerken, G., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.029 · Cited by 162
Self-citationBieghs, V., Wouters, K., van Gorp, P. J., Gijbels, M. J. J., de Winther, M. P. J., Binder, C. J., Lütjohann, D., Febbraio, M., Moore, K. J., van Bilsen, M., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.051 · Cited by 160
LIM, J., Lee, H., HOJUNG, M., & Song, J. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.004 · Cited by 156
Czaja, M. J. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00527.2009 · Cited by 153
Hubbard, B. K., Doege, H., Punreddy, S., Wu, H., Huang, X., Kaushik, V. K., Mozell, R. L., BYRNES, J. J., Stricker‐Krongrad, A., Chou, C. J., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.012 · Cited by 136
Orellana-Gavaldà, J. M., Herrero, L., Malandrino, M. I., Pañeda, A., Sol Rodríguez-Peña, M., Petry, H., Asins, G., Van Deventer, S., Hegardt, F. G., & Serra, D. (2011) · Hepatology · doi:10.1002/hep.24140 · Cited by 135
Wang, Y., Singh, R., Xiang, Y., & Czaja, M. J. (2010) · Hepatology · doi:10.1002/hep.23645 · Cited by 135
Novel Insights into the Pathophysiology of Nonalcoholic Fatty Liver Disease
Feldstein, A. E. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1267539 · Cited by 134
Lipotoxicity: Why do saturated fatty acids cause and monounsaturates protect against it?
Nolan, C. J., & Larter, C. Z. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05823.x · Cited by 132
Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo†
Yu, J. Q., Qiao, L., Zimmermann, L., Ebert, M. P., Zhang, H., Lin, W., Röcken, C., Malfertheiner, P., & Farrell, G. C. (2005) · Hepatology · doi:10.1002/hep.20994 · Cited by 130
Profiling of promoter occupancy by PPARα in human hepatoma cells via ChIP-chip analysis
van der Meer, D. L. M., Degenhardt, T., Vaïsänen, S., de Groot, P. J., Heinäniemi, M., de Vries, S. C., Müller, M. M., Carlberg, C., & Kersten, S. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq012 · Cited by 130
Abnormalities of Lipid Metabolism in Nonalcoholic Fatty Liver Disease
Cheung, O., & Sanyal, A. J. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091979 · Cited by 127
Bechmann, L. P., Gieseler, R. K. H., Sowa, J., Kahraman, A., ERHARD, J., Wedemeyer, I., Emons, B., Jochum, C., Feldkamp, T., Gerken, G., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2010.02248.x · Cited by 127
Self-citationRecent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance
Savage, D. B., & Semple, R. K. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833b7782 · Cited by 121
Hakimi, P., Johnson, M. T., Yang, J., LePage, D. F., Conlon, R. A., Kalhan, S. C., Reshef, L., Tilghman, S. M., & Hanson, R. W. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-33 · Cited by 121
Springsteen, B. (1984) · Cited by 113
Low Doses of Insulin-Like Growth Factor-I Induce Mitochondrial Protection in Aging Rats
Puche, J. E., Garcia‐Fernandez, M. I., Muntané, J., Rioja, J., González-Barón, S., & Castilla‐Cortázar, I. (2008) · Endocrinology · doi:10.1210/en.2007-1563 · Cited by 112
Carbohydrate Metabolism and the Liver: Actual Aspects from Physiology and Disease
Raddatz, D., & Ramadori, G. P. (2007) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2006-927394 · Cited by 102
Apoptosis in HepG2 cells exposed to high glucose
Chandrasekaran, K., Swaminathan, K., Chatterjee, S., & Dey, A. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.10.020 · Cited by 99
Conti, R., Mannucci, E., Pessotto, P., Tassoni, E., Carminati, P., Giannessi, F., & Arduini, A. (2011) · Diabetes · doi:10.2337/db10-0346 · Cited by 98
Zhou, S., Stump, D. D., Sorrentino, D. R., Potter, B. J., & Berk, P. D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49734-2 · Cited by 96
Handy, J. A., Saxena, N. K., Pingping, F., Lin, S., Mells, J. E., Gupta, N. A., & Anania, F. A. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22634 · Cited by 95
Miller, S. P., Anand, G. R., Karschnia, E. J., Bell, G. I., LaPorte, D. C., & Lange, A. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1645 · Cited by 91
Okiyama, W., Tanaka, N., Nakajima, T., Tanaka, E., Kiyosawa, K., Gonzalez, F. J., & Aoyama, T. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.025 · Cited by 90
Regulation of the Fatty Acid Synthase Promoter by Insulin
Sul, H. S., Latasa, M.-J., Moon, Y., & Kim, K. (2000) · Journal of Nutrition · doi:10.1093/jn/130.2.315s · Cited by 89
Akkaoui, M., Cohen, I., Esnous, C., Lenoir, V., Sournac, M., Girard, J. R., & Prip‐Buus, C. (2009) · Biochemical Journal · doi:10.1042/bj20081932 · Cited by 86
Wang, X., Wang, Z., Liu, J. Z., Hu, J. X., Chen, H. L., Li, W., & Hai, C. X. (2011) · Toxicology in Vitro · doi:10.1016/j.tiv.2011.02.004 · Cited by 82
Born to run; the story of the PEPCK-Cmus mouse
Hanson, R. W., & Hakimi, P. (2008) · Biochimie · doi:10.1016/j.biochi.2008.03.009 · Cited by 80
Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma
Wu, J.-M., Skill, N. J., & Maluccio, M. A. (2010) · HPB · doi:10.1111/j.1477-2574.2010.00207.x · Cited by 79
Cao, R., Cronk, Z. X., Zha, W., Sun, L., Wang, X., Fang, Y., Studer, E. J., Zhou, H., Pandak, W. M., Dent, P., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m004929 · Cited by 73
Chu, C. A., Fujimoto, Y., Igawa, K., Grimsby, J. S., Grippo, J. F., Magnuson, M. A., Cherrington, A. D., & Shiota, M. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00218.2003 · Cited by 70
Petta, S., & Craxı̀, A. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790883787 · Cited by 65
Horoz, M., Bölükbaş, C., Bolukbas, F. F., Sabuncu, T., Aslan, M., Sarifakiogullari, S., Gunaydin, N., & Erel, Ö. (2005) · BMC Gastroenterology · doi:10.1186/1471-230x-5-35 · Cited by 62
Ge, F., Zhou, S., Hu, C., Lobdell, H., & Berk, P. D. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00434.2009 · Cited by 62
Sajan, M. P., Standaert, M. L., Rivas, J., Miura, A., Kanoh, Y., Soto, J., Taniguchi, C. M., Kahn, C. R., & Farese, R. V. (2009) · Diabetologia · doi:10.1007/s00125-009-1336-5 · Cited by 60
Martin, G., Nemoto, M., Gelman, L., Geffroy, S., Najïb, J., Fruchart, J., Roevens, P. W. M., de Martinville, B., Deeb, S. S., & Auwerx, J. H. (2000) · Genomics · doi:10.1006/geno.2000.6191 · Cited by 60
Aberrant hepatic TRIB3 gene expression in insulin-resistant obese humans
Oberkofler, H., Pfeifenberger, A., Soyal, S. M., Felder, T. K., Hahne, P., Miller, K., Krempler, F., & Patsch, W. (2010) · Diabetologia · doi:10.1007/s00125-010-1772-2 · Cited by 59
Clinical Heterogeneity in Monogenic Diabetes Caused by Mutations in the Glucokinase Gene (GCK-MODY)
Cuesta-Muñoz, A. L., Tuomilehto, J., Cobo‐Vuilleumier, N., Rajala, H. L. M., Odili, S., Stride, A., Buettger, C. W., Otonkoski, T., Froguel, P., Grimsby, J. S., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0681 · Cited by 54
Berk, P. D. (2008) · Hepatology · doi:10.1002/hep.22632 · Cited by 52
Civera, M., Urios, A., García-Torres, M. L., Ortega, J., Martínez-Valls, J. F., Fernández, N. C., del Olmo, J. A., Ferrandez, A., Rodrigo, J. M., & Montoliu, C. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1070 · Cited by 49
Adiponectin deficiency impairs liver regeneration through attenuating STAT3 phosphorylation in mice
Shu, R., Zhang, F., Wang, F., Feng, D., Li, X., Ren, W., Wu, X.-L., Yang, X. F., Liao, X., Huang, L. H., et al. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.63 · Cited by 49
Central role of mitochondria in metabolic regulation of liver pathophysiology
Sato, N. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04963.x · Cited by 44
Roles of GSK3 in metabolic shift toward abnormal anabolism in cell senescence
Kim, Y., Seo, Y., Park, C., Yoon, S., & Yoon, G. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05617.x · Cited by 44
Effects of farnesoid X receptor on the expression of the fatty acid synthetase and hepatic lipase
Shen, L., Liu, H., Jiahe, P., Gan, L., Lu, L., Zhang, Q., Li, L., He, F., & Jiang, Y. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0140-0 · Cited by 41
Berk, P. D., Zhou, S., & Bradbury, M. W. (2005) · PubMed · Cited by 35
Wierzbicki, M., Chabowski, A., Zendzian-Piotrowska, M., & Górski, J. (2009) · PubMed · Cited by 29
Geier, A., & Trautwein, C. (2006) · Hepatology · doi:10.1002/hep.21521 · Cited by 18
Nonalcoholic Fatty Liver Disease progresses to HCC in the absence of apparent Cirrhosis
Ertle, J., Dechêne, A., Sowa, J., Penndorf, V., Herzer, K., Kaiser, G. M., Schlaak, J., Gerken, G., & Canbay, A. E. (2011) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0030-1269537 · Cited by 10
Self-citationRosselli, M. S., Burgueño, A. L., Pirola, C. J., & Sookoian, S. C. (2011) · Hepatology · doi:10.1002/hep.24309 · Cited by 5
Cited by
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
Ipsen, D. H., Lykkesfeldt, J., & Tveden-Nyborg, P. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2860-6 · Cited by 1,471
Trefts, E., Gannon, M., & Wasserman, D. H. (2017) · Current Biology · doi:10.1016/j.cub.2017.09.019 · Cited by 1,452
Lipidomics for studying metabolism
Han, X. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.98 · Cited by 718
From NAFLD to NASH to cirrhosis—new insights into disease mechanisms
Wree, A., Broderick, L., Canbay, A., Hoffman, H. M., & Feldstein, A. E. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.149 · Cited by 609
Self-citationNon-alcoholic fatty liver disease and obesity: Biochemical, metabolic and clinical presentations
Milić, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i28.9330 · Cited by 583
Metadata
- Authors
- Bechmann, L. P., Hannivoort, R. A., Gerken, G., Hotamisligil, G. S., Trauner, M., & Canbay, A.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 56
- Issue
- 4
- Pages
- 952-964
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2095591310
- Cited by
- 994
- References
- 133
- FWCI
- 18.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.